VEDANTA PARTNERS, LLC 3

3 · REVIVA PHARMACEUTICALS HOLDINGS, INC. · Filed Jun 3, 2021

Insider Transaction Report

Form 3
Period: 2021-06-01
Holdings
  • Common Stock

    (indirect: See Footnote)
    99,539
Footnotes (1)
  • [F1]Held directly by Vedanta Associates, L.P. ("Vedanta Associates"). Vedanta Partners, LLC ("Vedanta Partners") is the general partner of Vedanta Associates, and Parag Saxena is the majority member of Vedanta Partners. Each of Vedanta Partners and Mr. Saxena disclaim beneficial ownership of the securities reported herein, except to the extent of any pecuniary interest therein.

Documents

1 file
  • 3
    form3.xmlPrimary

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES